News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
ImClone Systems to Pay Abbott Laboratories $17.5 Million to End Lawsuit
August 11, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Aug. 8 (Bloomberg) -- ImClone Systems Inc., maker of the Erbitux cancer drug, agreed to pay Abbott Laboratories $17.5 million to end a patent-infringement lawsuit over the medicine.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Abbott Laboratories
MORE ON THIS TOPIC
IN PARTNERSHIP WITH CRESSET
Why AI Won’t Save the 90% of Clinical Trials That Still Fail
August 21, 2025
·
1 min read
·
Lori Ellis
Government
Hundreds of HHS Staffers Accuse RFK Jr. of ‘Sowing Public Mistrust’ Against CDC After Shooting at HQ
August 21, 2025
·
2 min read
·
Tristan Manalac
Vaccines
American Academy of Pediatrics Contradicts CDC, Recommends COVID-19 Shot for Kids
August 20, 2025
·
2 min read
·
Tristan Manalac
Regulatory
Conflicts of Interest in Vaccine Committees Have Been Plunging for Decades
August 19, 2025
·
4 min read
·
Dan Samorodnitsky
